"During the twelve months ended 30 June 2013, the Company completed feasibility testing and formulation
development for two initial Vitamin D formulations which have been enhanced using Imugene? proprietary Linguet
drug delivery technology."
Completed!
Our research has been supported by discussions held with Australian nutraceutical companies. The vitamins and supplements industry is big business in Australia, worth an estimated $1.5bn each year and the industry is growing at up to 12% annually.
Supported!
Next should be an agreement!
In June 2013, Imugene contracted IDT Australia to manufacture its ibuprofen tablets.
Contracted!
"During the twelve months ended 30 June 2013, the Company...
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.9¢ | $900.1K | 18.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 102 | 15456501 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 1713619 | 8 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |